A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19
出版年份 2021 全文链接
标题
A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19
作者
关键词
-
出版物
JOURNAL OF CLINICAL IMMUNOLOGY
Volume 42, Issue 1, Pages 19-24
出版商
Springer Science and Business Media LLC
发表日期
2021-10-29
DOI
10.1007/s10875-021-01166-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2
- (2021) Romain Lévy et al. JOURNAL OF CLINICAL IMMUNOLOGY
- When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It
- (2021) Stefano Cappanera et al. Journal of Clinical Medicine
- Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
- (2021) Anthony Touafchia et al. CLINICAL MICROBIOLOGY AND INFECTION
- Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
- (2021) Paul Bastard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of Toll‐like receptors in the pathogenesis of COVID‐19
- (2021) Shaghayegh Khanmohammadi et al. JOURNAL OF MEDICAL VIROLOGY
- Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial
- (2021) Ilad Alavi Darazam et al. Scientific Reports
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
- (2021) Paul Bastard et al. Science Immunology
- SARS-CoV-2: An Insight into Detection Tools
- (2021) Shaghayegh Khanmohammadi et al. Infectious Disorders - Drug Targets
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
- (2020) Christopher J.A. Duncan et al. TRENDS IN GENETICS
- Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients
- (2020) Zhong-Jie Hu et al. Frontiers in Immunology
- The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
- (2020) Gideon Schreiber Frontiers in Immunology
- A novel case of homozygous IFNAR1 deficiency with haemophagocytic lymphohistiocytosis
- (2020) Florian Gothe et al. CLINICAL INFECTIOUS DISEASES
- Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency
- (2020) Paul Bastard et al. JOURNAL OF CLINICAL INVESTIGATION
- Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
- (2019) Anping Li et al. Journal of Hematology & Oncology
- Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines
- (2019) Nicholas Hernandez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection
- (2016) Armstrong Murira et al. Frontiers in Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started